Novel insights into the epigenetics of diffuse glioma

Loss-of-function mutations of the chromatin regulator ATRX (α-thalassemia mental retardation X-linked) occur frequently in diffuse gliomas, but the molecular mechanisms by which ATRX inactivation promotes oncogenesis remain unclear. We recently reported that Atrx deficiency drives glioma-relevant ph...

Full description

Bibliographic Details
Main Authors: Carla Danussi, Jason T. Huse
Format: Article
Language:English
Published: Taylor & Francis Group 2018-09-01
Series:Molecular & Cellular Oncology
Subjects:
Online Access:http://dx.doi.org/10.1080/23723556.2018.1472055
_version_ 1797677171748110336
author Carla Danussi
Jason T. Huse
author_facet Carla Danussi
Jason T. Huse
author_sort Carla Danussi
collection DOAJ
description Loss-of-function mutations of the chromatin regulator ATRX (α-thalassemia mental retardation X-linked) occur frequently in diffuse gliomas, but the molecular mechanisms by which ATRX inactivation promotes oncogenesis remain unclear. We recently reported that Atrx deficiency drives glioma-relevant phenotypes, such as increased motility and astrocytic differentiation profiles, by directly modulating epigenomic lanscapes in glioma cells of origin. Our work has significant implications on the role of epigenetic regulator dysfunction in the oncogenic process.
first_indexed 2024-03-11T22:41:12Z
format Article
id doaj.art-cbc8d771285c4926aa39ab929aab9129
institution Directory Open Access Journal
issn 2372-3556
language English
last_indexed 2024-03-11T22:41:12Z
publishDate 2018-09-01
publisher Taylor & Francis Group
record_format Article
series Molecular & Cellular Oncology
spelling doaj.art-cbc8d771285c4926aa39ab929aab91292023-09-22T09:10:59ZengTaylor & Francis GroupMolecular & Cellular Oncology2372-35562018-09-015510.1080/23723556.2018.14720551472055Novel insights into the epigenetics of diffuse gliomaCarla Danussi0Jason T. Huse1University of Texas MD Anderson Cancer CenterUniversity of Texas MD Anderson Cancer CenterLoss-of-function mutations of the chromatin regulator ATRX (α-thalassemia mental retardation X-linked) occur frequently in diffuse gliomas, but the molecular mechanisms by which ATRX inactivation promotes oncogenesis remain unclear. We recently reported that Atrx deficiency drives glioma-relevant phenotypes, such as increased motility and astrocytic differentiation profiles, by directly modulating epigenomic lanscapes in glioma cells of origin. Our work has significant implications on the role of epigenetic regulator dysfunction in the oncogenic process.http://dx.doi.org/10.1080/23723556.2018.1472055atrxgliomacancer genomicsepigenomicshistonesneuroepithelial progenitorsmigrationdifferentiation
spellingShingle Carla Danussi
Jason T. Huse
Novel insights into the epigenetics of diffuse glioma
Molecular & Cellular Oncology
atrx
glioma
cancer genomics
epigenomics
histones
neuroepithelial progenitors
migration
differentiation
title Novel insights into the epigenetics of diffuse glioma
title_full Novel insights into the epigenetics of diffuse glioma
title_fullStr Novel insights into the epigenetics of diffuse glioma
title_full_unstemmed Novel insights into the epigenetics of diffuse glioma
title_short Novel insights into the epigenetics of diffuse glioma
title_sort novel insights into the epigenetics of diffuse glioma
topic atrx
glioma
cancer genomics
epigenomics
histones
neuroepithelial progenitors
migration
differentiation
url http://dx.doi.org/10.1080/23723556.2018.1472055
work_keys_str_mv AT carladanussi novelinsightsintotheepigeneticsofdiffuseglioma
AT jasonthuse novelinsightsintotheepigeneticsofdiffuseglioma